UBS analyst Kevin McVeigh lowered the firm’s price target on ASGN (ASGN) to $47 from $49 and keeps a Sell rating on the shares. The firm remains cautious amid continued core uncertainty, the analyst tells investors in a research note.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ASGN:
- ASGN’s Mixed Financial Signals and Macroeconomic Challenges Lead to Hold Rating
- ASGN price target lowered to $51 from $56 at Wells Fargo
- ASGN Incorporated Surpasses Revenue Expectations in Q2 2025
- ASGN reports Q2 adjusted EPS $1.17, consensus $1.08
- ASGN sees Q3 adjusted EPS $1.18-$1.26, consensus $1.22